Objectives: The loss of function of the E-cadherin (CDH1) gene with -160 C→A and -347 G→GA polymorphisms is regarded as a critical step for gastric cancer. It was aimed to investigate possible association of these polymorphisms and immunoexpression of E-cadherin with gastric cancer.
Material And Methods: Gastric adenocarcinoma patients and individuals with benign gastric pathologies were included in this case-control study.